- Home
- TARA vs SMTI Comparison
TARA vs SMTI Comparison
Compare TARA & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- SMTI
- Stock Information
- Founded
- TARA N/A
- SMTI 1982
- Country
- TARA United States
- SMTI United States
- Employees
- TARA N/A
- SMTI N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- SMTI Medical/Dental Instruments
- Sector
- TARA Health Care
- SMTI Health Care
- Exchange
- TARA Nasdaq
- SMTI Nasdaq
- Market Cap
- TARA 165.5M
- SMTI 192.5M
- IPO Year
- TARA N/A
- SMTI N/A
- Fundamental
- Price
- TARA $7.59
- SMTI $19.85
- Analyst Decision
- TARA Strong Buy
- SMTI Strong Buy
- Analyst Count
- TARA 7
- SMTI 2
- Target Price
- TARA $20.33
- SMTI $41.00
- AVG Volume (30 Days)
- TARA 613.6K
- SMTI 61.5K
- Earning Date
- TARA 11-10-2025
- SMTI 11-12-2025
- Dividend Yield
- TARA N/A
- SMTI N/A
- EPS Growth
- TARA N/A
- SMTI N/A
- EPS
- TARA N/A
- SMTI N/A
- Revenue
- TARA N/A
- SMTI $101,877,532.00
- Revenue This Year
- TARA N/A
- SMTI $24.49
- Revenue Next Year
- TARA N/A
- SMTI $14.43
- P/E Ratio
- TARA N/A
- SMTI N/A
- Revenue Growth
- TARA N/A
- SMTI 30.52
- 52 Week Low
- TARA $2.28
- SMTI $18.90
- 52 Week High
- TARA $10.48
- SMTI $38.75
- Technical
- Relative Strength Index (RSI)
- TARA 77.80
- SMTI 31.75
- Support Level
- TARA $5.00
- SMTI $18.90
- Resistance Level
- TARA $6.85
- SMTI $22.65
- Average True Range (ATR)
- TARA 0.55
- SMTI 1.75
- MACD
- TARA 0.24
- SMTI -0.50
- Stochastic Oscillator
- TARA 99.43
- SMTI 13.01
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.